Owner and Operations Manager of Wholesale Drug Distributor Admit Conspiring to Divert Nearly $50m of Cancer Medication to Sell Illegally For Profit

NEWARK, N.J. – Two North Jersey men have admitted to conspiring with doctors and others to purchase nearly $50 million worth of oncology and ophthalmology medications, under false pretenses, and then diverting and reselling these medications for profit, Senior Counsel Philip Lamparello announced. Frank Incognito, 46, of Englishtown, New Jersey, and Stephen Corba, 50, of Farmingdale, New Jersey, have pleaded guilty before U.S. District Judge Susan D. Wigenton to conspiring to unlawfully resell various medications, including expensive oncology and ophthalmology medications, that a healthcare entity previously purchased. Corba entered his guilty plea earlier today, while Incognito entered his guilty plea on February 18, 2026. According to documents filed in this case and statements made in court: For years, Corba owned and ran a wholesale drug distributor, operating under New Jersey corporations located in Sewaren, New Jersey. During this time, Incognito worked as the operations manager of this drug distributor. Corba and Incognito conspired with each other and multiple doctors to obtain expensive prescription medications that Corba and Incognito otherwise would not have been able to obtain on their own. These medications were first “straw-purchased” through the doctors’ medical practices, using the doctors’ medical licenses, and on the express condition that the medications would be used to treat the doctors’ own patients. After the medications were purchased, Corba, Incognito, the doctors, and their co-conspirators illegally transferred and resold the medications to others. Primarily, these medications were cold-chain biologic infusion medications that physicians typically use to treat cancers, macular degeneration, and autoimmune diseases. In order to purchase the drugs, Corba, Incognito, and the doctors made numerous false and misleading representations to the pharmaceutical manufacturers and authorized distributors. These misrepresentations included that the doctors were purchasing the drugs to treat their own patients, and that the drugs would not be resold or redistributed to others. In actuality, none of the drugs were used to treat any of the doctors’ own patients but were instead sold to customers of Corba and Incognito, for a profit. Corba’s and Incognito’s fraudulent scheme ran from June 2012 through January 2019, and included the purchase and sale of more than $47.5 million in prescription drugs. Doctors Anise Kachadourian, Jon Paul Dadaian, and Joel Lerner also previously pled guilty to their roles in the scheme. The conspiracy to which Corba and Incognito pleaded guilty is punishable by a maximum of five years in prison and a $250,000 fine. In their plea agreement, Corba and Incognito also agreed to make restitution for the full amount of any losses resulting from their offenses. Sentencing for Incognito is scheduled for June 23, 2026, and sentencing for Corba is scheduled for July 8, 2026.